Comparing ALGN and PAYC: A Deep Dive into Volatility, Price Growth, and Earnings Reports
Compare: Swing Trader for Beginners: Exits from Low Volatility to Explosive Movements (TA&FA) 6.32% for ALGN vs Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) 6.58% for PAYC
A Brief Overview of Swing Trading Strategies
To start, let's briefly touch on the Swing Trading strategies referenced for ALGN and PAYC. The Swing Trader for Beginners: Exits from Low Volatility to Explosive Movements (TA&FA) strategy delivered a return of 6.32% for ALGN, while the Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA) approach gave a return of 6.58% for PAYC. Though these strategies have unique characteristics, both apply technical and fundamental analysis (TA&FA) to navigate market volatility and trends.
The Exits from Low Volatility to Explosive Movements strategy typically involves trading stocks that exhibit periods of low volatility followed by large price movements, whereas Trading in Markets Trending Up strategy generally capitalizes on securities in an upward market trend.
Weekly Price Growth: ALGN vs. PAYC
For the week, ALGN, which operates in the Medical Specialties industry, enjoyed a price increase of 2.56%. In contrast, PAYC, part of the Packaged Software industry, experienced a price drop of 2.34%.
When comparing these numbers to their respective industries, ALGN performed much stronger than its peers with an average weekly price drop of 0.89% in the Medical Specialties sector. PAYC, on the other hand, outperformed its industry, where the average weekly price drop was 1.07%.
Monthly and Quarterly Price Growth: An Industry Perspective
Taking a wider lens, the average monthly and quarterly price growth in the Medical Specialties industry (home to ALGN) was -0.37% and +7.41%, respectively. For the Packaged Software sector (home to PAYC), these figures were +3.70% and a robust +23.99%. The Packaged Software industry, hence, appears to have experienced higher growth over the more extended periods, underlining the importance of considering industry performance when comparing individual stocks.
Upcoming Earnings Reports
As for future expectations, both companies are due to report earnings soon. ALGN is set to announce its earnings on July 26, 2023, while PAYC is expected to report on August 1, 2023. These reports could potentially influence stock prices and should be closely monitored by investors.
In conclusion, while both ALGN and PAYC offer attractive opportunities for swing trading, they do so in distinct market contexts. Traders and investors should bear in mind these differences when devising their strategies and keep a keen eye on the upcoming earnings reports. The ongoing performance of these two companies reaffirms the importance of not only examining individual stocks but also the industries within which they operate.
On May 09, 2025, the Stochastic Oscillator for ALGN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 52 instances where the indicator left the oversold zone. In of the 52 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The Moving Average Convergence Divergence (MACD) for ALGN just turned positive on April 09, 2025. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
ALGN moved above its 50-day moving average on April 23, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ALGN crossed bullishly above the 50-day moving average on April 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .
ALGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 252 cases where ALGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for ALGN moved out of overbought territory on April 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALGN as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.609) is normal, around the industry mean (24.089). P/E Ratio (55.007) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (1.991) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (6.337) is also within normal values, averaging (42.249).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of the invisalign system for treating malocclusion
Industry MedicalSpecialties